BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 24810045)

  • 1. Metformin lowers Ser-129 phosphorylated α-synuclein levels via mTOR-dependent protein phosphatase 2A activation.
    Pérez-Revuelta BI; Hettich MM; Ciociaro A; Rotermund C; Kahle PJ; Krauss S; Di Monte DA
    Cell Death Dis; 2014 May; 5(5):e1209. PubMed ID: 24810045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin, an antidiabetic agent reduces growth of cutaneous squamous cell carcinoma by targeting mTOR signaling pathway.
    Chaudhary SC; Kurundkar D; Elmets CA; Kopelovich L; Athar M
    Photochem Photobiol; 2012; 88(5):1149-56. PubMed ID: 22540890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin prevents tobacco carcinogen--induced lung tumorigenesis.
    Memmott RM; Mercado JR; Maier CR; Kawabata S; Fox SD; Dennis PA
    Cancer Prev Res (Phila); 2010 Sep; 3(9):1066-76. PubMed ID: 20810672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin: a novel promising option for fertility preservation during cyclophosphamide-based chemotherapy.
    Huang CC; Chou CH; Yang YS; Ho HN; Shun CT; Wen WF; Chen SU; Chen MJ
    Mol Hum Reprod; 2021 Jan; 27(1):. PubMed ID: 33543290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serine 129 phosphorylation reduces the ability of alpha-synuclein to regulate tyrosine hydroxylase and protein phosphatase 2A in vitro and in vivo.
    Lou H; Montoya SE; Alerte TN; Wang J; Wu J; Peng X; Hong CS; Friedrich EE; Mader SA; Pedersen CJ; Marcus BS; McCormack AL; Di Monte DA; Daubner SC; Perez RG
    J Biol Chem; 2010 Jun; 285(23):17648-61. PubMed ID: 20356833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin alters the insulin signaling pathway in ischemic cardiac tissue in a swine model of metabolic syndrome.
    Elmadhun NY; Lassaletta AD; Chu LM; Sellke FW
    J Thorac Cardiovasc Surg; 2013 Jan; 145(1):258-65; discussion 265-6. PubMed ID: 23083540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioproteomics modeling of metformin-enhanced radiosensitivity: an animal study.
    Cheki M; Mostafaei S; Hanafi MG; Farasat M; Talaiezadeh A; Ghasemi MS; Modava M; Abdollahi H
    Jpn J Radiol; 2023 Nov; 41(11):1265-1274. PubMed ID: 37204669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro modulation of mTOR and mGlur5 influence α-synuclein accumulation.
    Xing V; Biggar K; Ferguson SSG; Hayley S
    Mol Brain; 2024 Feb; 17(1):9. PubMed ID: 38360671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dephosphorylation and inactivation of Akt/PKB is counteracted by protein kinase CK2 in HEK 293T cells.
    Di Maira G; Brustolon F; Pinna LA; Ruzzene M
    Cell Mol Life Sci; 2009 Oct; 66(20):3363-73. PubMed ID: 19662498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards natural mimetics of metformin and rapamycin.
    Aliper A; Jellen L; Cortese F; Artemov A; Karpinsky-Semper D; Moskalev A; Swick AG; Zhavoronkov A
    Aging (Albany NY); 2017 Nov; 9(11):2245-2268. PubMed ID: 29165314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulation of protein phosphatase 2A in parkinson disease and dementia with lewy bodies.
    Park HJ; Lee KW; Park ES; Oh S; Yan R; Zhang J; Beach TG; Adler CH; Voronkov M; Braithwaite SP; Stock JB; Mouradian MM
    Ann Clin Transl Neurol; 2016 Oct; 3(10):769-780. PubMed ID: 27752512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3β-MCL-1 Axis.
    Elgendy M; Cirò M; Hosseini A; Weiszmann J; Mazzarella L; Ferrari E; Cazzoli R; Curigliano G; DeCensi A; Bonanni B; Budillon A; Pelicci PG; Janssens V; Ogris M; Baccarini M; Lanfrancone L; Weckwerth W; Foiani M; Minucci S
    Cancer Cell; 2019 May; 35(5):798-815.e5. PubMed ID: 31031016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights on the potential anti-epileptic effect of metformin: Mechanistic pathway.
    Alnaaim SA; Al-Kuraishy HM; Al-Gareeb AI; Ali NH; Alexiou A; Papadakis M; Saad HM; Batiha GE
    J Cell Mol Med; 2023 Dec; 27(24):3953-3965. PubMed ID: 37737447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deciphering metformin action in obese mice: A critical re-evaluation of established protocols.
    Kaplanian M; Philippe C; Eid SA; Hackl MT; Metz M; Beghini M; Luca AC; Kautzky-Willer A; Scherer T; Fürnsinn C
    Metabolism; 2022 Mar; 128():154956. PubMed ID: 34953917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin in Esophageal Carcinoma: Exploring Molecular Mechanisms and Therapeutic Insights.
    Papadakos SP; Argyrou A; Lekakis V; Arvanitakis K; Kalisperati P; Stergiou IE; Konstantinidis I; Schizas D; Koufakis T; Germanidis G; Theocharis S
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression of protein kinase AMP-activated catalytic subunit alpha 1 (PRKAA1), solute carrier family 2 member 1 (SLC2A1) and mechanistic target of rapamycin (MTOR) in metformin-treated type 2 diabetes patients with COVID-19: impact on inflammation markers.
    Petakh P; Kamyshna I; Kamyshnyi A
    Inflammopharmacology; 2024 Feb; 32(1):885-891. PubMed ID: 37773574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic physiological α-synuclein S129 phosphorylation is driven by neuronal activity.
    Ramalingam N; Jin SX; Moors TE; Fonseca-Ornelas L; Shimanaka K; Lei S; Cam HP; Watson AH; Brontesi L; Ding L; Hacibaloglu DY; Jiang H; Choi SJ; Kanter E; Liu L; Bartels T; Nuber S; Sulzer D; Mosharov EV; Chen WV; Li S; Selkoe DJ; Dettmer U
    NPJ Parkinsons Dis; 2023 Jan; 9(1):4. PubMed ID: 36646701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aging and TOR: interwoven in the fabric of life.
    Sharp ZD
    Cell Mol Life Sci; 2011 Feb; 68(4):587-97. PubMed ID: 20960025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel therapeutic approach to colorectal cancer in diabetes: role of metformin and rapamycin.
    Geagea AG; Rizzo M; Jurjus A; Cappello F; Leone A; Tomasello G; Gracia C; Al Kattar S; Massaad-Massade L; Eid A
    Oncotarget; 2019 Feb; 10(13):1284-1305. PubMed ID: 30863490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lac-Phe mediates the effects of metformin on food intake and body weight.
    Xiao S; Li VL; Lyu X; Chen X; Wei W; Abbasi F; Knowles JW; Tung AS; Deng S; Tiwari G; Shi X; Zheng S; Farrell L; Chen ZZ; Taylor KD; Guo X; Goodarzi MO; Wood AC; Chen YI; Lange LA; Rich SS; Rotter JI; Clish CB; Tahir UA; Gerszten RE; Benson MD; Long JZ
    Nat Metab; 2024 Apr; 6(4):659-669. PubMed ID: 38499766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.